share_log

Corvus Pharma Q4 EPS $(0.14) Misses $(0.12) Estimate

Corvus Pharma Q4 EPS $(0.14) Misses $(0.12) Estimate

Corvus Pharma第四季度每股收益美元(0.14美元)未达到预期(0.12美元)
Benzinga ·  03/19 16:04

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 33.33 percent increase over losses of $(0.21) per share from the same period last year.

Corvus Pharma(纳斯达克股票代码:CRVS)公布的季度亏损为每股0.14美元,比分析师普遍预期的0.12美元(0.12美元)低16.67%。这比去年同期每股亏损0.21美元(0.21美元)增长了33.33%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发